% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Schulze:274047,
      author       = {Schulze, Jan Ben and Dörner, Marc and Huber, Mona and
                      Jordan, Katja-Daniela and Känel, Roland von and Euler,
                      Sebastian},
      title        = {{P}sychiatric {D}iagnoses and {T}heir {T}reatment in
                      {W}omen {W}ith {B}reast {C}ancer: {A} {L}atent {C}lass
                      {A}nalysis of 1062 {I}npatients.},
      journal      = {Clinical breast cancer},
      volume       = {25},
      number       = {1},
      issn         = {1526-8209},
      address      = {Dallas, Tex.},
      publisher    = {Cancer Information Group},
      reportid     = {DZNE-2025-00028},
      pages        = {e22 - e29},
      year         = {2025},
      abstract     = {Psycho-oncological support (POS) and psychopharmacological
                      interventions are effective in treating psychiatric symptoms
                      in patients with breast cancer. However, despite high
                      prevalences of psychiatric disorders in patients with breast
                      cancer, a significant proportion remains untreated.Data from
                      1062 breast cancer patients who had been diagnosed and
                      treated at a Comprehensive Cancer Center between 2012 and
                      2019 were analyzed retrospectively. We descriptively
                      evaluated the number of patients with a psychiatric
                      diagnosis, POS and psychiatric medication. Latent class
                      analysis was used to examine the relationship between ICD-10
                      coded psychiatric diagnoses, POS, psychiatric medication,
                      and, as important prognostic factors, tumor stage and
                      somatic $comorbidity.31.5\%$ of all patients had a
                      psychiatric diagnosis, $20\%$ received POS and up to $60\%$
                      received psychiatric medication. Latent class analysis
                      revealed three subgroups: 1) patients with a low cancer
                      stage, low somatic comorbidity, no psychiatric diagnosis, no
                      POS and no psychiatric medication; 2) patients with a low
                      cancer stage, low somatic comorbidity, a psychiatric
                      diagnosis, and a higher probability of POS and psychiatric
                      medication than class 1 and class 3; 3) patients with
                      advanced cancer stage, high somatic comorbidity, a higher
                      probability of a psychiatric diagnosis and POS than class 1,
                      and no psychiatric medication.This study indicated a high
                      prevalence of psychiatric disorders among patients with
                      breast cancer and a discrepancy between the number of
                      patients having a psychiatric disorder and those receiving
                      psychiatric medication. The identification of subgroups
                      might contribute to better tailored treatment for those
                      patients whose needs are insufficiently met.},
      keywords     = {Humans / Female / Breast Neoplasms: psychology / Breast
                      Neoplasms: therapy / Breast Neoplasms: pathology / Mental
                      Disorders: epidemiology / Middle Aged / Retrospective
                      Studies / Adult / Latent Class Analysis / Aged / Comorbidity
                      / Prevalence / Inpatients: psychology / Inpatients:
                      statistics $\&$ numerical data / Prognosis / Psychotropic
                      Drugs: therapeutic use / Breast cancer (Other) / Psychiatric
                      comorbidity (Other) / Psychiatric medication (Other) /
                      Psychiatric treatment (Other) / Psycho-oncology (Other) /
                      Psychotropic Drugs (NLM Chemicals)},
      cin          = {AG Schreiber},
      ddc          = {610},
      cid          = {I:(DE-2719)1310010},
      pnm          = {353 - Clinical and Health Care Research (POF4-353)},
      pid          = {G:(DE-HGF)POF4-353},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:39153934},
      doi          = {10.1016/j.clbc.2024.06.011},
      url          = {https://pub.dzne.de/record/274047},
}